Verapamil Toxicity Dysregulates the Phosphatidylinositol 3‐Kinase Pathway

Article Properties
Abstract
Cite
Bechtel, Laura K., et al. “Verapamil Toxicity Dysregulates the Phosphatidylinositol 3‐Kinase Pathway”. Academic Emergency Medicine, vol. 15, no. 4, 2008, pp. 368-74, https://doi.org/10.1111/j.1553-2712.2008.00088.x.
Bechtel, L. K., Haverstick, D. M., & Holstege, C. P. (2008). Verapamil Toxicity Dysregulates the Phosphatidylinositol 3‐Kinase Pathway. Academic Emergency Medicine, 15(4), 368-374. https://doi.org/10.1111/j.1553-2712.2008.00088.x
Bechtel, Laura K., Doris M. Haverstick, and Christopher P. Holstege. “Verapamil Toxicity Dysregulates the Phosphatidylinositol 3‐Kinase Pathway”. Academic Emergency Medicine 15, no. 4 (2008): 368-74. https://doi.org/10.1111/j.1553-2712.2008.00088.x.
1.
Bechtel LK, Haverstick DM, Holstege CP. Verapamil Toxicity Dysregulates the Phosphatidylinositol 3‐Kinase Pathway. Academic Emergency Medicine. 2008;15(4):368-74.
Journal Categories
Medicine
Internal medicine
Medical emergencies
Critical care
Intensive care
First aid
Medicine
Internal medicine
Special situations and conditions
Medicine
Medicine (General)
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Differential sorting of two glucose transporters expressed in insulin‐sensitive cells 1991
Cytoplasmic Ca2+ during differentiation of 3T3‐L1 adipocytes. Effect of insulin and relation to glucose transport Journal of Biological Chemistry
  • Science: Chemistry: Organic chemistry: Biochemistry
 1987
Toxicology in ECC Circulation
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Medicine (General)
 2005
Part 12: Pediatric Advanced Life Support Circulation
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Medicine (General)
 2005
Diverse effects of calcium channel blockers on skeletal muscle glucose transport 1992
Citations
Title Journal Journal Categories Citations Publication Date
Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor Acta Pharmaceutica Sinica B
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
 14 2022
Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
 26 2021
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
 28 2020
Verapamil prevents the effect of calcium-sensing receptor activation on the blood glucose and insulin levels in rats Pharmacological Reports
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
 2019
A Case of Life-threatening Amlodipine and Atenolol Overdose Indian Journal of Critical Care Medicine
  • Medicine: Internal medicine: Medical emergencies. Critical care. Intensive care. First aid
 8 2019
Citations Analysis
Category Category Repetition
Medicine: Public aspects of medicine: Toxicology. Poisons14
Medicine: Therapeutics. Pharmacology10
Medicine: Medicine (General)9
Medicine: Internal medicine: Medical emergencies. Critical care. Intensive care. First aid7
Medicine: Internal medicine: Special situations and conditions4
Science: Chemistry: Analytical chemistry2
Science: Chemistry2
Medicine2
Science: Biology (General)2
Science: Chemistry: Organic chemistry: Biochemistry2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system2
Science1
Science: Science (General)1
Technology: Chemical technology: Biotechnology1
Science: Microbiology1
Medicine: Internal medicine1
Medicine: Surgery: Anesthesiology1
Science: Physiology1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
Medicine: Pediatrics1
The category Medicine: Public aspects of medicine: Toxicology. Poisons 14 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled High dose insulin in toxic cardiogenic shock and was published in 2009. The most recent citation comes from a 2022 study titled Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor. This article reached its peak citation in 2011, with 5 citations. It has been cited in 27 different journals, 22% of which are open access. Among related journals, the Clinical Toxicology cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year